Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jacquelyn Bainbridge

Concepts (192)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anticonvulsants
6
2020
253
1.430
Why?
Parkinson Disease
11
2024
614
1.040
Why?
Seizures
5
2017
489
0.630
Why?
Multiple Sclerosis
2
2016
435
0.580
Why?
Drug Resistant Epilepsy
1
2020
145
0.540
Why?
Education, Pharmacy
2
2017
125
0.510
Why?
Pharmacy
1
2017
32
0.500
Why?
Quality of Life
3
2020
3200
0.480
Why?
Neurology
1
2017
107
0.470
Why?
Psychotropic Drugs
1
2016
75
0.460
Why?
Antiparkinson Agents
3
2017
41
0.430
Why?
Disability Evaluation
1
2016
297
0.420
Why?
Laboratory Proficiency Testing
1
2014
9
0.420
Why?
Monitoring, Immunologic
1
2014
25
0.410
Why?
CD3 Complex
1
2014
113
0.400
Why?
CD4 Lymphocyte Count
1
2014
280
0.390
Why?
Laboratories
1
2014
109
0.390
Why?
Creatine
4
2017
63
0.390
Why?
Epilepsy
4
2020
400
0.380
Why?
Immunophenotyping
1
2014
324
0.380
Why?
4-Aminopyridine
1
2012
30
0.370
Why?
Potassium Channel Blockers
1
2012
47
0.370
Why?
Gait Disorders, Neurologic
1
2012
43
0.360
Why?
Cannabidiol
2
2024
142
0.330
Why?
Immunotherapy
1
2016
671
0.330
Why?
Dronabinol
3
2024
251
0.320
Why?
Drug Interactions
5
2016
405
0.310
Why?
Piracetam
1
2009
14
0.300
Why?
Gait
1
2012
322
0.290
Why?
Fructose
2
2008
132
0.290
Why?
Restless Legs Syndrome
3
2016
20
0.290
Why?
Clinical Trials as Topic
1
2014
1064
0.280
Why?
Monoamine Oxidase Inhibitors
1
2008
20
0.280
Why?
Monoamine Oxidase
1
2008
27
0.280
Why?
CD8-Positive T-Lymphocytes
1
2014
931
0.260
Why?
Walking
1
2012
546
0.260
Why?
CD4-Positive T-Lymphocytes
1
2014
1150
0.260
Why?
Epistaxis
1
2006
16
0.240
Why?
Caffeine
2
2017
77
0.230
Why?
Abdominal Neoplasms
1
2025
48
0.220
Why?
Cannabinoids
2
2025
182
0.220
Why?
Diabetic Neuropathies
1
2006
101
0.220
Why?
Patient Compliance
1
2009
589
0.210
Why?
Depression
3
2009
1575
0.190
Why?
Disease Progression
4
2017
2867
0.170
Why?
Pain
1
2006
790
0.160
Why?
Humans
31
2025
146342
0.160
Why?
Volatilization
1
2019
45
0.150
Why?
Nebulizers and Vaporizers
1
2019
63
0.150
Why?
Dopamine Agonists
2
2016
41
0.150
Why?
Ketosis
1
1999
12
0.150
Why?
Starvation
1
1999
21
0.150
Why?
Pharmaceutical Services
1
1999
76
0.140
Why?
HIV Infections
1
2014
3215
0.140
Why?
Cannabis
2
2023
521
0.140
Why?
Comorbidity
2
2016
1665
0.130
Why?
Dibenzazepines
1
2017
5
0.130
Why?
Severity of Illness Index
5
2017
2921
0.130
Why?
Schools, Pharmacy
1
2017
48
0.130
Why?
Practice Guidelines as Topic
2
2016
1591
0.120
Why?
Double-Blind Method
5
2024
2070
0.120
Why?
Analgesics, Opioid
1
2025
1221
0.120
Why?
Metabolic Diseases
1
2017
114
0.120
Why?
Air Pollution
1
2019
314
0.120
Why?
Female
19
2025
79499
0.120
Why?
Teratogens
1
2015
25
0.110
Why?
Contraceptives, Oral, Hormonal
1
2015
30
0.110
Why?
Drug Synergism
1
2016
354
0.110
Why?
Receptors, N-Methyl-D-Aspartate
1
2017
233
0.110
Why?
Cognition
1
2023
1292
0.100
Why?
Psychiatry
1
2017
191
0.100
Why?
Pharmacists
1
2017
260
0.100
Why?
Monitoring, Physiologic
1
2016
279
0.100
Why?
Male
15
2025
73396
0.100
Why?
Treatment Outcome
4
2024
11821
0.100
Why?
Quality Control
1
2014
163
0.100
Why?
Electrocardiography
1
2017
667
0.100
Why?
Lactation
1
2014
193
0.100
Why?
Observer Variation
1
2014
356
0.100
Why?
Combined Modality Therapy
1
2016
1271
0.090
Why?
Heart Rate
1
2017
846
0.090
Why?
Computer Simulation
1
2017
1014
0.090
Why?
Prognosis
2
2025
4351
0.090
Why?
Aged
10
2025
26432
0.090
Why?
Workflow
1
2014
182
0.090
Why?
Specimen Handling
1
2014
178
0.090
Why?
Postoperative Complications
1
2025
3034
0.090
Why?
Physical Therapy Modalities
1
2016
341
0.090
Why?
Data Interpretation, Statistical
1
2014
368
0.090
Why?
Program Development
1
2014
371
0.090
Why?
Middle Aged
13
2025
36619
0.090
Why?
Quality Indicators, Health Care
1
2014
343
0.080
Why?
Drug Costs
1
2012
116
0.080
Why?
Follow-Up Studies
3
2025
5439
0.080
Why?
Purines
1
2012
188
0.080
Why?
Aged, 80 and over
4
2015
8391
0.080
Why?
Flow Cytometry
1
2014
1163
0.080
Why?
Curriculum
1
2017
1079
0.080
Why?
Models, Statistical
1
2014
669
0.080
Why?
Program Evaluation
1
2014
952
0.080
Why?
Guideline Adherence
1
2014
594
0.070
Why?
Epilepsies, Partial
1
2009
62
0.070
Why?
Pregnancy Complications
1
2014
609
0.070
Why?
Predictive Value of Tests
1
2014
2113
0.070
Why?
Patient Selection
1
2012
728
0.070
Why?
Reproducibility of Results
2
2014
3416
0.070
Why?
Recovery of Function
1
2012
725
0.070
Why?
Pyrazoles
1
2012
517
0.070
Why?
Genetic Predisposition to Disease
1
2017
2488
0.070
Why?
Citalopram
1
2008
33
0.070
Why?
Polypharmacy
1
2009
94
0.070
Why?
Health Services
1
2008
112
0.060
Why?
Memory Disorders
1
2009
198
0.060
Why?
Time Factors
2
2017
7109
0.060
Why?
Mental Disorders
1
2016
1148
0.060
Why?
Community Pharmacy Services
1
2007
46
0.060
Why?
Accreditation
1
2007
100
0.060
Why?
Adult
8
2025
41087
0.060
Why?
Risk Assessment
1
2016
3712
0.060
Why?
Pharmacy Service, Hospital
1
2007
90
0.060
Why?
Drug Therapy, Combination
1
2008
1036
0.060
Why?
Data Collection
1
2008
650
0.060
Why?
Kidney Diseases
1
2009
428
0.060
Why?
Longitudinal Studies
3
2017
3017
0.050
Why?
Quality Improvement
1
2014
1354
0.050
Why?
Neoplasms
1
2020
2954
0.050
Why?
Physician-Patient Relations
1
2009
597
0.050
Why?
Patient Education as Topic
1
2009
770
0.050
Why?
Dose-Response Relationship, Drug
3
2017
2022
0.050
Why?
Chronic Disease
1
2009
1827
0.050
Why?
Biomarkers
1
2014
4340
0.050
Why?
Drug Administration Schedule
2
2017
790
0.040
Why?
2-Propanol
1
2019
20
0.040
Why?
Limit of Detection
1
2019
92
0.040
Why?
Food-Drug Interactions
1
1999
11
0.040
Why?
Diet, Protein-Restricted
1
1999
11
0.040
Why?
Calibration
1
2019
154
0.040
Why?
Spectrometry, Mass, Electrospray Ionization
1
2019
175
0.040
Why?
Clinical Competence
1
2007
1272
0.040
Why?
Surface Properties
1
2019
384
0.030
Why?
Dietary Carbohydrates
1
1999
146
0.030
Why?
Risk Factors
1
2012
10921
0.030
Why?
Catechol O-Methyltransferase Inhibitors
1
1997
6
0.030
Why?
Environmental Monitoring
1
2019
346
0.030
Why?
Dietary Fats
1
1999
307
0.030
Why?
Drug Evaluation, Preclinical
1
2017
195
0.030
Why?
Autonomic Nervous System
1
2017
82
0.030
Why?
Tandem Mass Spectrometry
1
2019
576
0.030
Why?
Marijuana Smoking
1
2019
249
0.030
Why?
Gene-Environment Interaction
1
2017
190
0.030
Why?
Women
1
2015
46
0.030
Why?
Hemodiafiltration
1
1995
7
0.030
Why?
Ciprofloxacin
1
1995
31
0.030
Why?
Prospective Studies
2
2025
8123
0.030
Why?
Enzyme Inhibitors
1
1997
823
0.030
Why?
Consensus
1
2016
467
0.020
Why?
Central Nervous System Stimulants
1
2015
183
0.020
Why?
Adenosine A2 Receptor Antagonists
1
2012
14
0.020
Why?
Counseling
1
2015
406
0.020
Why?
Evidence-Based Medicine
1
2016
731
0.020
Why?
Radionuclide Imaging
1
2012
116
0.020
Why?
Pregnancy
2
2015
7230
0.020
Why?
Palliative Care
1
2020
1032
0.020
Why?
Genotype
1
2017
1879
0.020
Why?
Diagnosis, Differential
1
2014
1503
0.020
Why?
Vasodilator Agents
1
2012
326
0.020
Why?
Animals
1
2012
38107
0.020
Why?
Sex Characteristics
1
2015
801
0.020
Why?
Age Factors
1
2017
3347
0.020
Why?
Polymorphism, Single Nucleotide
1
2017
2240
0.020
Why?
Exercise Test
1
2012
637
0.020
Why?
Periodicity
1
2008
57
0.020
Why?
Headache
1
2008
150
0.020
Why?
Recurrence
1
2008
1133
0.010
Why?
Pilot Projects
1
2008
1888
0.010
Why?
Young Adult
1
2015
14330
0.010
Why?
Ergolines
1
1997
3
0.010
Why?
Catechols
1
1997
14
0.010
Why?
Benzophenones
1
1997
16
0.010
Why?
Nitrophenols
1
1997
30
0.010
Why?
Benzothiazoles
1
1997
39
0.010
Why?
Retrospective Studies
1
2015
17438
0.010
Why?
Colorado
1
2007
4595
0.010
Why?
Thiazoles
1
1997
139
0.010
Why?
Receptors, Dopamine D2
1
1997
93
0.010
Why?
Nitriles
1
1997
212
0.010
Why?
Adolescent
1
2015
22557
0.010
Why?
Liver Failure
1
1995
79
0.010
Why?
Indoles
1
1997
511
0.010
Why?
Chromatography, High Pressure Liquid
1
1995
588
0.010
Why?
Critical Illness
1
1995
908
0.000
Why?
Acute Kidney Injury
1
1995
866
0.000
Why?
Bainbridge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)